BRPI0820198A2 - composições farmacêuticas - Google Patents
composições farmacêuticasInfo
- Publication number
- BRPI0820198A2 BRPI0820198A2 BRPI0820198A BRPI0820198A BRPI0820198A2 BR PI0820198 A2 BRPI0820198 A2 BR PI0820198A2 BR PI0820198 A BRPI0820198 A BR PI0820198A BR PI0820198 A BRPI0820198 A BR PI0820198A BR PI0820198 A2 BRPI0820198 A2 BR PI0820198A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98717807P | 2007-11-12 | 2007-11-12 | |
PCT/US2008/082932 WO2009064681A2 (en) | 2007-11-12 | 2008-11-10 | Liquid compositions comprising valsartan |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0820198A2 true BRPI0820198A2 (pt) | 2019-09-24 |
Family
ID=40639403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0820198A BRPI0820198A2 (pt) | 2007-11-12 | 2008-11-10 | composições farmacêuticas |
Country Status (10)
Country | Link |
---|---|
US (2) | US20100267787A1 (pt) |
EP (2) | EP2222273A2 (pt) |
JP (1) | JP2011503105A (pt) |
KR (1) | KR20100087002A (pt) |
CN (1) | CN101854913A (pt) |
BR (1) | BRPI0820198A2 (pt) |
CA (1) | CA2705453A1 (pt) |
MX (1) | MX2010005198A (pt) |
RU (2) | RU2488393C2 (pt) |
WO (1) | WO2009064681A2 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101993436B1 (ko) * | 2011-10-31 | 2019-06-26 | 노바르티스 아게 | 파조파닙 제형 |
WO2013098268A2 (en) * | 2011-12-26 | 2013-07-04 | Novartis Ag | Tablets and dry-coated agents |
ES2584248B1 (es) * | 2015-03-24 | 2017-04-19 | Farmalider, S.A. | Composición farmacéutica de citrato de sildenafilo en forma de suspensión para uso oral |
CN105596305A (zh) * | 2015-12-25 | 2016-05-25 | 华润赛科药业有限责任公司 | 一种高稳定性的缬沙坦制剂及其制备方法 |
WO2017191619A2 (en) * | 2016-05-06 | 2017-11-09 | Sun Pharmaceutical Industries Limited | A process for the preparation of a salt of sacubitril and valsartan |
WO2018204040A1 (en) * | 2017-05-01 | 2018-11-08 | Bioramo, Llc | Oral liquid compositions of valsartan |
US10478422B1 (en) * | 2018-12-14 | 2019-11-19 | ECI Pharmaceuticals, LLC | Oral liquid compositions including valsartan |
US11413275B1 (en) | 2018-12-14 | 2022-08-16 | ECI Pharmaceuticals, LLC | Oral liquid compositions including valsartan |
US10548838B1 (en) | 2018-12-14 | 2020-02-04 | ECI Pharmaceuticals, LLC | Oral liquid compositions including valsartan |
US11446243B1 (en) | 2019-08-05 | 2022-09-20 | ECI Pharmaceuticals, LLC | Oral liquid compositions including valsartan |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE122007000050I1 (de) | 1990-02-19 | 2007-11-08 | Novartis Ag | Acylverbindungen |
GB9200247D0 (en) * | 1992-01-07 | 1992-02-26 | Erba Carlo Spa | Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation |
ES2309090T3 (es) | 2000-07-19 | 2008-12-16 | Novartis Ag | Sales de valsartan. |
HUP0500843A2 (hu) * | 2001-12-20 | 2005-12-28 | Bristol-Myers Squibb Co., | Fokozott biológiai hasznosulású, szájon át hatásos taxánszármazékokat tartalmazó gyógyszerkészítmények |
US20040247588A1 (en) * | 2002-08-28 | 2004-12-09 | Johnson Robert E. | Formulations of modified antibodies and methods of making the same |
TWI327913B (en) * | 2003-03-12 | 2010-08-01 | Novartis Ag | Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid |
PE20050985A1 (es) * | 2003-11-21 | 2005-11-26 | Schering Corp | Formulaciones de inhibidores de la fosfodiesterasa v |
US20070026026A1 (en) * | 2005-08-01 | 2007-02-01 | David Delmarre | Oral liquid losartan compositions |
RU2487710C2 (ru) * | 2007-10-09 | 2013-07-20 | Новартис Аг | Фармацевтическая композиция валсартана |
-
2008
- 2008-11-10 EP EP08850984A patent/EP2222273A2/en not_active Withdrawn
- 2008-11-10 EP EP10177744A patent/EP2316422A1/en not_active Withdrawn
- 2008-11-10 CN CN200880115379A patent/CN101854913A/zh active Pending
- 2008-11-10 KR KR1020107010332A patent/KR20100087002A/ko not_active Application Discontinuation
- 2008-11-10 JP JP2010533312A patent/JP2011503105A/ja active Pending
- 2008-11-10 BR BRPI0820198A patent/BRPI0820198A2/pt not_active IP Right Cessation
- 2008-11-10 US US12/741,857 patent/US20100267787A1/en not_active Abandoned
- 2008-11-10 CA CA2705453A patent/CA2705453A1/en not_active Abandoned
- 2008-11-10 MX MX2010005198A patent/MX2010005198A/es unknown
- 2008-11-10 WO PCT/US2008/082932 patent/WO2009064681A2/en active Application Filing
- 2008-11-10 RU RU2010123691/15A patent/RU2488393C2/ru not_active IP Right Cessation
-
2012
- 2012-12-20 US US13/721,521 patent/US20130109729A1/en not_active Abandoned
-
2013
- 2013-01-11 RU RU2013101018/15A patent/RU2013101018A/ru unknown
Also Published As
Publication number | Publication date |
---|---|
CA2705453A1 (en) | 2009-05-11 |
AU2008321159A1 (en) | 2009-05-22 |
WO2009064681A2 (en) | 2009-05-22 |
RU2013101018A (ru) | 2014-07-20 |
RU2488393C2 (ru) | 2013-07-27 |
US20130109729A1 (en) | 2013-05-02 |
WO2009064681A3 (en) | 2009-10-08 |
EP2316422A1 (en) | 2011-05-04 |
JP2011503105A (ja) | 2011-01-27 |
CN101854913A (zh) | 2010-10-06 |
EP2222273A2 (en) | 2010-09-01 |
MX2010005198A (es) | 2010-05-20 |
RU2010123691A (ru) | 2011-12-20 |
KR20100087002A (ko) | 2010-08-02 |
US20100267787A1 (en) | 2010-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTC2140867I2 (lt) | Farmacinė kompozicija | |
LTPA2018014I1 (lt) | Farmacinė kompozicija 514 | |
RU2493831C3 (ru) | Фармацевтические композиции | |
SMT201600259B (it) | Composizioni farmaceutiche antibatteriche | |
BRPI0721651A2 (pt) | Composição farmacêutica | |
BRPI0715712A2 (pt) | Composição farmacêutica | |
DK2079456T3 (da) | Farmaceutiske cyclosporinsammensætninger | |
BRPI0810634A2 (pt) | Composições fungicidas | |
BRPI0820381A2 (pt) | Formulações farmacêuticas | |
BRPI0719393A2 (pt) | Composição farmacêutica | |
DK2120884T3 (da) | Farmaceutisk sammensætning | |
BRPI0813775A2 (pt) | Composição | |
ATE528048T1 (de) | Schweisshemmende/desodorierende zusammensetzung | |
BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
BRPI1012539A2 (pt) | composições farmacêuticas | |
BRPI0720234A2 (pt) | Composição farmacêutica | |
DK2285413T3 (da) | Farmaceutisk sammensætning | |
BRPI0810557A2 (pt) | composição | |
BRPI0811274A2 (pt) | Composição | |
IT1394400B1 (it) | Composizioni farmaceutiche | |
BRPI0820198A2 (pt) | composições farmacêuticas | |
BRPI0921313A2 (pt) | composição farmaucêutica | |
BRPI0817833A2 (pt) | Composição farmacêutica antimalárica | |
DK2966175T3 (da) | Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat | |
BRPI0811002A2 (pt) | Composição biofertilizante |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |